<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02416596</url>
  </required_header>
  <id_info>
    <org_study_id>ASMH-RH1</org_study_id>
    <nct_id>NCT02416596</nct_id>
  </id_info>
  <brief_title>Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility</brief_title>
  <official_title>Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate the impact of hysteroscopy prior to starting the
      IVF (in vitro fertilisation) cycle on treatment outcome in women with unexplained primary
      infertility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proper history, examination and investigations are carried out to diagnose causes of
      infertility. Office hysteroscopy will be performed during the Luteal phase of the proceeding
      menstrual cycle using a rigid hysteroscope. Controlled ovarian hyper stimulation-embryo
      transfer (COH-ET) using the standard long protocol of induction used in Ain Shams University
      Maternity Hospitals ART (assisted reproductive techniques) unit.

      Biochemical pregnancy will be determined by a positive pregnancy test performed 2 weeks after
      embryo transfer and clinical pregnancy will be defined by the presence of a gestational sac
      using transvaginal ultrasound performed 6 weeks after embryo transfer.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biochemical Pregnancy</measure>
    <time_frame>2-6 weeks</time_frame>
    <description>Pregnancy determined by chemical test (2 weeks) and vag. U/S (ultrasound) (6 weeks)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">680</enrollment>
  <condition>Primary Infertility Unspecified</condition>
  <condition>Infertility</condition>
  <condition>Ovarian Hyperstimulation</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Group Undergoing Hysterosopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will include 340 women with unexplained primary infertility undergoing their first trial of IVF/ICSI (intracytoplasmic sperm injection). This group will undergo hysteroscopy in the mid luteal phase of the proceeding cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group With No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will include 340 women with unexplained primary infertility they will undergo their first trial of IVF/ICSI (intracytoplasmic sperm injection) without hysteroscopy in the mid Luteal phase of the proceeding cycle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysteroscopy</intervention_name>
    <description>Office hysteroscopy will be performed during the Luteal phase of the proceeding menstrual cycle.
All OH (office hysteroscopy) procedures will be performed with a vaginoscopic approach without utilizing a speculum and applying traction to the cervix with a tenaculum.
Antibiotic prophylaxis: None OH will be cancelled until after treatment of vaginal infection.</description>
    <arm_group_label>Group Undergoing Hysterosopy</arm_group_label>
    <other_name>ROH: Routine Office Hysteroscopy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hysteroscope</intervention_name>
    <description>The device used is a rigid hysteroscope (continuous flow, 30 degree forward oblique view) assembled in a 4-mm diameter diagnostic sheath with an atraumatic tip (Karl Storz Endoscopy).
Illumination: High intensity cold light source and fiberoptic cable Distention medium: solution of 0.9% normal saline with pressure at 100-120 mmHg</description>
    <arm_group_label>Group Undergoing Hysterosopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing IVF/ICSI using the standard long GnRH-a (gonadotropin-releasing
             hormone-a) protocol.

          -  No evidence of uterine pathology by transvaginal ultrasound and hysterosalpingography
             during the follicular phase.

          -  Patients with unexplained primary infertility.

        Exclusion Criteria:

          -  Patients undergoing IVF using other protocols of induction.

          -  Patients with evidence of uterine pathology by transvaginal ultrasound or
             hysterosalpingography during the follicular phase.

          -  Other causes of infertility rather than unexplained factor.

          -  Unexplained poor responders during the pending ICSI cycle.

          -  Patients with abnormal findings at hysteroscopy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaled H Swaydan, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams University (Obs&amp;Gyn)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed K Mekled, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Ain Shams University (Obs&amp;Gyn)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amr A. Abdulreheem, MBBCh</last_name>
    <phone>+201006774459</phone>
    <email>amro984@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Moustafa F Gomaa, PhD</last_name>
    <phone>01226188993</phone>
  </overall_contact_backup>
  <reference>
    <citation>El-Toukhy T, Sunkara SK, Coomarasamy A, Grace J, Khalaf Y. Outpatient hysteroscopy and subsequent IVF cycle outcome: a systematic review and meta-analysis. Reprod Biomed Online. 2008 May;16(5):712-9. Review.</citation>
    <PMID>18492377</PMID>
  </reference>
  <reference>
    <citation>Pundir J, Pundir V, Omanwa K, Khalaf Y, El-Toukhy T. Hysteroscopy prior to the first IVF cycle: a systematic review and meta-analysis. Reprod Biomed Online. 2014 Feb;28(2):151-61. doi: 10.1016/j.rbmo.2013.09.025. Epub 2013 Oct 5. Review.</citation>
    <PMID>24365027</PMID>
  </reference>
  <reference>
    <citation>Loverro G, Nappi L, Vicino M, Carriero C, Vimercati A, Selvaggi L. Uterine cavity assessment in infertile women: comparison of transvaginal sonography and hysteroscopy. Eur J Obstet Gynecol Reprod Biol. 2001 Dec 10;100(1):67-71.</citation>
    <PMID>11728660</PMID>
  </reference>
  <reference>
    <citation>Karayalçin R, Ozyer S, Ozcan S, Uzunlar O, Gürlek B, Moraloğlu O, Batioğlu S. Office hysteroscopy improves pregnancy rates following IVF. Reprod Biomed Online. 2012 Sep;25(3):261-6. doi: 10.1016/j.rbmo.2012.05.013. Epub 2012 Jun 16.</citation>
    <PMID>22818094</PMID>
  </reference>
  <reference>
    <citation>De Placido G, Clarizia R, Cadente C, Castaldo G, Romano C, Mollo A, Alviggi C, Conforti S. Compliance and diagnostic efficacy of mini-hysteroscopy versus traditional hysteroscopy in infertility investigation. Eur J Obstet Gynecol Reprod Biol. 2007 Nov;135(1):83-7. Epub 2007 May 3.</citation>
    <PMID>17481803</PMID>
  </reference>
  <reference>
    <citation>Almog B, Shalom-Paz E, Dufort D, Tulandi T. Promoting implantation by local injury to the endometrium. Fertil Steril. 2010 Nov;94(6):2026-9. doi: 10.1016/j.fertnstert.2009.12.075. Epub 2010 Feb 19. Review.</citation>
    <PMID>20171615</PMID>
  </reference>
  <reference>
    <citation>Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril. 2003 Jun;79(6):1317-22.</citation>
    <PMID>12798877</PMID>
  </reference>
  <reference>
    <citation>Bosteels J, Weyers S, Puttemans P, Panayotidis C, Van Herendael B, Gomel V, Mol BW, Mathieu C, D'Hooghe T. The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review. Hum Reprod Update. 2010 Jan-Feb;16(1):1-11. doi: 10.1093/humupd/dmp033. Review.</citation>
    <PMID>19744944</PMID>
  </reference>
  <reference>
    <citation>Huang LN, Tan J, Hitkari J, Dahan MH. Should IVF be used as first-line treatment or as a last resort? A debate presented at the 2013 Canadian Fertility and Andrology Society meeting. Reprod Biomed Online. 2015 Feb;30(2):128-36. doi: 10.1016/j.rbmo.2014.10.004. Epub 2014 Oct 14. Review.</citation>
    <PMID>25498596</PMID>
  </reference>
  <reference>
    <citation>Hughes E, Brown J, Collins JJ, Vanderkerchove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000057. doi: 10.1002/14651858.CD000057.pub2. Review.</citation>
    <PMID>20091498</PMID>
  </reference>
  <reference>
    <citation>Lea RG, Sandra O. Immunoendocrine aspects of endometrial function and implantation. Reproduction. 2007 Sep;134(3):389-404. Review.</citation>
    <PMID>17709558</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2015</study_first_submitted>
  <study_first_submitted_qc>April 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2015</study_first_posted>
  <last_update_submitted>April 10, 2015</last_update_submitted>
  <last_update_submitted_qc>April 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Amr Abdulreheem</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>ICSI</keyword>
  <keyword>IVF</keyword>
  <keyword>hysteroscopy</keyword>
  <keyword>Supervision</keyword>
  <keyword>In-vitro Fertilization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

